NCT02868008

Brief Summary

Microsurgical resection for eloquent arteriovenous malformations (AVMs) remains challenging. Currently, there are only two grading systems concerning pretreatment assessment of brain AVMs: the Spetzler-Martin grading system proposed by Spetzler and Martin in 1986 and the supplementary grading system proposed by Lawton in 2010. Controversies exist regarding the treatment timing and treatment modalities for eloquent AVMs. Till now, there is no clinical trial concerning the efficacy of multimodal magnetic resonance imaging techniques in assessing the surgical risk for eloquent AVMs. The investigators assume that multimodal imaging-based grading system is superior to the classic Spetzler-Martin grading system and the supplementary grading system in predicting the surgical risk for eloquent AVMs.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 25, 2016

Completed
22 days until next milestone

First Posted

Study publicly available on registry

August 16, 2016

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

August 16, 2016

Status Verified

August 1, 2016

Enrollment Period

3 years

First QC Date

July 25, 2016

Last Update Submit

August 13, 2016

Conditions

Keywords

multimodal imagingsurgical riskarteriovenous malformations

Outcome Measures

Primary Outcomes (1)

  • neurologic status measured by modified Rankin scale score

    the changes of modified Rankin scale (mRS) score six months after AVM surgery compared with the presurgical mRS score

    six months after AVM surgery

Secondary Outcomes (7)

  • number of patient deaths

    within 6 months after surgery

  • AVM obliteration confirmed by postoperative DSA or CTA

    within one week after surgery

  • AVM rebleeding confirmed by CT scan

    within 6 months after surgery

  • Seizure control measured by Engel classification

    within 6 months after surgery

  • muscle strength measured by muscle strength grading scale

    6 months after surgery

  • +2 more secondary outcomes

Study Arms (1)

fMRI guided AVM resection

EXPERIMENTAL

fMRI guided microsurgical resection of brain AVMs

Procedure: Microsurgical resection of brain AVMs

Interventions

fMRI guided microsurgical resection of brain AVMs

fMRI guided AVM resection

Eligibility Criteria

Age12 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients aged between 12 and 60 years
  • Data from preoperative structural MRI, blood oxygen level dependent (BOLD)-fMRI, time-of-flight magnetic resonance angiography (TOF-MRA), and DTI of the motor tract,language tract or optic radiation were available
  • Patients with a definite diagnosis of AVM confirmed by preoperative digital subtraction angiography
  • Patients opting for surgical management at the five centers in this study
  • Patients without any interventional therapy (microsurgery, radiosurgery, endovascular embolization, or multimodality treatment) before admission to the five centers

You may not qualify if:

  • Patients with acute intracranial hematoma and resultant brain hernia prompting emergency surgery
  • Patients with a hemorrhagic incident in the past month
  • Nonavailability of BOLD-fMRI and DTI data
  • Patients with other severe diseases that prevented them from having surgery
  • Patients unwilling to participate in the trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Tiantan Hospital, Capital Medical University

Beijing, Beijing Municipality, 100050, China

RECRUITING

Related Publications (4)

  • Wen Z, Zheng K, Guo S, Liu Y, Wang K, Liu Q, Wu J, Wang S. The difference of functional MR imaging in evaluating outcome of patients with diffuse and compact brain arteriovenous malformation. Neurosurg Rev. 2024 Jul 24;47(1):347. doi: 10.1007/s10143-024-02593-9.

  • Jiao Y, Lin F, Wu J, Li H, Fu W, Huo R, Cao Y, Wang S, Zhao J. Plasticity in language cortex and white matter tracts after resection of dominant inferior parietal lobule arteriovenous malformations: a combined fMRI and DTI study. J Neurosurg. 2020 Mar 20;134(3):953-960. doi: 10.3171/2019.12.JNS191987. Print 2021 Mar 1.

  • Li M, Jiang P, Guo R, Liu Q, Yang S, Wu J, Cao Y, Wang S. A Tractography-Based Grading Scale of Brain Arteriovenous Malformations Close to the Corticospinal Tract to Predict Motor Outcome After Surgery. Front Neurol. 2019 Jul 17;10:761. doi: 10.3389/fneur.2019.00761. eCollection 2019.

  • Tong X, Wu J, Cao Y, Zhao Y, Wang S. New predictive model for microsurgical outcome of intracranial arteriovenous malformations: study protocol. BMJ Open. 2017 Jan 27;7(1):e014063. doi: 10.1136/bmjopen-2016-014063.

MeSH Terms

Conditions

Intracranial Arteriovenous MalformationsArteriovenous Malformations

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCentral Nervous System Vascular MalformationsNervous System MalformationsVascular MalformationsCardiovascular AbnormalitiesCardiovascular DiseasesVascular DiseasesIntracranial Arterial DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Shuo Wang, M.D.

    Beijing Tiantan Hospital

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 25, 2016

First Posted

August 16, 2016

Study Start

June 1, 2016

Primary Completion

June 1, 2019

Study Completion

December 1, 2019

Last Updated

August 16, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will not share

Locations